Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ryan Specialty Holdings (RYAN) Cash & Equivalents (2020 - 2025)

Ryan Specialty Holdings (RYAN) has disclosed Cash & Equivalents for 6 consecutive years, with $158.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 70.69% to $158.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $158.3 million, a 70.69% decrease, with the full-year FY2025 number at $158.3 million, down 70.69% from a year prior.
  • Cash & Equivalents was $158.3 million for Q4 2025 at Ryan Specialty Holdings, up from $153.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $2.0 billion in Q2 2023 to a low of $153.5 million in Q3 2025.
  • A 5-year average of $955.4 million and a median of $911.0 million in 2021 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 393.09% in 2021, then plummeted 90.1% in 2025.
  • Ryan Specialty Holdings' Cash & Equivalents stood at $1.1 billion in 2021, then surged by 55.08% to $1.8 billion in 2022, then plummeted by 52.54% to $838.8 million in 2023, then plummeted by 35.6% to $540.2 million in 2024, then plummeted by 70.69% to $158.3 million in 2025.
  • Per Business Quant, the three most recent readings for RYAN's Cash & Equivalents are $158.3 million (Q4 2025), $153.5 million (Q3 2025), and $172.6 million (Q2 2025).